Results 171 to 180 of about 37,448 (280)

Oral health: Asthma and oral candidiasis [PDF]

open access: yesBritish Dental Journal, 2017
J S, Chandan, R S, Randhawa, T, Thomas
openaire   +2 more sources

Paraneoplastic Pemphigus/Paraneoplastic Autoimmune Multiorgan Syndrome Associated With Castleman Disease: Multidisciplinary Management of a Rare Life‐Threatening Syndrome

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Refractory oral erosions or polymorphous eruptions should prompt evaluation for paraneoplastic pemphigus, particularly when associated with mediastinal masses. Early tumor excision, multidisciplinary care, and vigilant monitoring for bronchiolitis obliterans are essential to improve outcomes in Castleman disease–associated paraneoplastic ...
Ayaan Sohail, Jessica Evans, Mika Tabata
wiley   +1 more source

Bilateral Basal Ganglia Calcification (Fahr's Syndrome) Secondary to Hypoparathyroidism: A Case Series

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Three cases of Fahr's syndrome presented with seizures and extrapyramidal features, all linked to hypoparathyroidism with disrupted calcium‐phosphate levels. CT confirmed basal ganglia calcification. Anticonvulsants, calcium, and vitamin D controlled seizures.
Ali Gohar   +8 more
wiley   +1 more source

Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. [PDF]

open access: yes, 1994
Bogner, Johannes R.   +7 more
core   +1 more source

Human Colitis‐on‐Chip Model Reveals Dual Roles of Butyrate in Epithelial and Macrophage Defense Against Candida albicans Tissue Invasion

open access: yesSmall, Volume 22, Issue 37, 2 July 2026.
This study establishes a human immunocompetent colitis‐on‐chip model that mimics inflamed gut mucosa and enables quantitative analysis of Candida albicans tissue invasion under DSS‐induced injury. It reveals that microbiota‐derived butyrate simultaneously stabilizes epithelial junctions and reprograms macrophages via HDAC/NLRP3‐dependent mechanisms ...
Manuel Allwang   +16 more
wiley   +1 more source

Evolving treatments for Sjögren disease: current approaches and emerging targets

open access: yesInternal Medicine Journal, Volume 56, Issue 7, Page 1126-1133, July 2026.
Abstract Sjögren disease (SjD) is a prevalent systemic autoimmune condition characterised by exocrine gland dysfunction, systemic inflammation and heterogeneous organ involvement. Current management remains largely symptomatic, with no approved disease‐modifying therapies available and substantial unmet clinical need. However, advances in understanding
Mansi Bhurani   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy